huberman retatrutide The Next Ozempic Isn't Just About Weight Loss It's About Rewriting Human Performance Andrew Huberman clarifies he is

2025;37:e51

GLP-1 and Fatty Liver Disease (NAFLD/NASH) GLP-1RAs show promising benefits in: Hepatic steatosis reduction Weight loss-mediated liver improvement Improved insulin resistance Reduced inflammation These agents are likely to become central therapies in metabolic-associated steatotic liver disease (MASLD)

The problem is that this premise ignores biology

Sleeve gastrostomy (SG) The laparoscopic SG comprises of partial resection of the greater curvature of the stomach

As of 2025, retatrutide has not received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) for routine clinical use in the UK

Advertisement If anxiety or stress causes your heart palpitations, you may be able to control them with calming activities like yoga, meditation or a mindfulness exercise that focuses on your breathing